心脏骤停中的上腺素:确定复苏的潜在极限
Zachary Boivin1, Kevin M Duignan1, Donias Doko1
1University of Connecticut, Emergency Medicine Residency, Farmington, Connecticut.
The western journal of emergency medicine
|January 2, 2024
概括
在心脏骤停时增加上腺素剂量与生存率下降有关. 七个或更多剂量的上腺素似乎是徒劳的,建议临床医生根据剂量计数重新考虑复苏工作.
科学领域:
- 紧急医疗 紧急医疗
- 心脏病学 心脏病学
- 临床研究 临床研究
背景情况:
- 上腺素是高级心脏生命支持 (ACLS) 的基石,尽管对改善神经完整生存的证据有限.
- 在现实世界中,上腺素的使用模式及其对患者结果的影响需要进一步调查.
研究的目的:
- 为了确定在复苏期间有效使用上腺素的上限.
- 为了分析各种患者子组的真实世界上腺素的管理.
主要方法:
- 一项追溯的队列研究,对1330名患有医学性心脏骤停的患者进行了追溯的队列研究,这些患者接受了已知数量的上腺素剂量.
- 主要结局:神经学上完好无损的释放 (修改的兰金尺度≤3).
- 二次结果:根据年龄,节奏和给药方式 (EMS与ED) 进行上腺素剂量比较.
主要成果:
- 随着上腺素剂量增加 (剂量0:65.4%;剂量1-3:20.0%;剂量4-6:4.3%;剂量≥7:0.002%),神经完整性排出率显著下降.
- 具有震动节律的患者比非震动节律的患者获得更多的上腺素.
- 上腺素的使用在不同年龄组中是相似的.
结论:
- 较高的上腺素剂量与显著较低的神经完整生存率有关.
- 七个或更多的上腺素剂量可能表明复苏工作的徒劳.
- 临床医生在评估持续复苏的益处与徒劳时,应考虑上腺素剂量的数量.
相关概念视频
01:30Adrenergic Agonists: Therapeutic Uses
781
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
781
02:06Allergic Reactions
27.4K
Overview
27.4K
01:19Depolarizing Blockers: Pharmocokinetics
327
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
327
01:30Cardiac Action Potential
1.5K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433